HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hemibody Irradiation

Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (UHBI) or lower hemibody irradiation (LHBI). Less common is mid-body irradiation (MBI). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called "systemic" hemibody irradiation with reference to its use in widespread cancer or metastases. (P. Rubin et al. Cancer, Vol 55, p2210, 1985)
Also Known As:
Hemi-Body Irradiation; Half Body Irradiation; Half-Body Irradiations; Hemi Body Irradiation; Hemi-Body Irradiations; Hemibody Irradiation, Sequential; Hemibody Irradiation, Systemic; Hemibody Irradiations; Hemibody Irradiations, Sequential; Hemibody Irradiations, Systemic; Irradiation, Half Body; Irradiation, Hemi-Body; Irradiation, Sequential Hemibody; Irradiation, Systemic Hemibody; Irradiations, Half-Body; Irradiations, Hemi-Body; Irradiations, Hemibody; Irradiations, Sequential Hemibody; Irradiations, Systemic Hemibody; Sequential Hemibody Irradiations; Systemic Hemibody Irradiations; Half-Body Irradiation; Irradiation, Half-Body; Irradiation, Hemibody; Sequential Hemibody Irradiation; Systemic Hemibody Irradiation
Networked: 140 relevant articles (9 outcomes, 24 trials/studies) for this Therapy, Comments

Relationship Network

Therapy Context: Research Results

Experts

1. Théon, A P: 2 articles (09/2009 - 12/2008)
2. Lurie, D M: 2 articles (09/2009 - 12/2008)
3. Kent, M S: 2 articles (09/2009 - 12/2008)
4. Terenziani, M: 2 articles (06/2005 - 07/2001)
5. Spreafico, F: 2 articles (06/2005 - 07/2001)
6. Massimino, M: 2 articles (06/2005 - 07/2001)
7. Luksch, R: 2 articles (06/2005 - 07/2001)
8. Gandola, L: 2 articles (06/2005 - 07/2001)
9. Fossati-Bellani, F: 2 articles (06/2005 - 07/2001)
10. Ferrari, A: 2 articles (06/2005 - 07/2001)

Related Diseases

1. Neoplasm Metastasis (Metastasis)
2. Neoplasms (Cancer)
3. Vomiting
4. Multiple Myeloma
5. Hematologic Neoplasms (Hematological Malignancy)

Related Drugs and Biologics

1. Antiemetics
2. Granisetron (Kytril)
3. Ondansetron (Zofran)
4. Teniposide (VM 26)
5. Serotonin (5 Hydroxytryptamine)
6. Misonidazole
7. Interferons
8. Carmustine (FIVB)
9. Radioisotopes (Radionuclides)
10. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Radioimmunotherapy
3. Radiotherapy
4. Combination Drug Therapy (Combination Chemotherapy)
5. Subcutaneous Injections

blog comments powered by Disqus
TREATMENT OPTIONS
for Neoplasm Metastasis,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 4426 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>